Close Menu

NEW YORK (GenomeWeb) – MDxHealth this morning reported that its revenues for the first half of 2017 have risen 87 percent, driven mostly by a one-time buy-out of patents related to colorectal cancer by Exact Sciences.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.